Fair pricing forum 2019 meeting report

In 2017, WHO convened the first Fair Pricing Forum in Amsterdam, The Netherlands, to enable stakeholders to discuss options for a fairer pricing system for pharmaceuticals.

The second Forum, held 11-13 April 2019 in Johannesburg, addressed the following objectives:

• To share experiences in employing regulatory and non-regulatory measures for achieving ‘fair’ prices for pharmaceutical products that are affordable to patients and healthcare systems while incentivizing enterprise, efficiency and innovation
• To explore tools, approaches and system factors that could facilitate affordable and sustainable pricing of pharmaceutical products
• To identify areas of actions that would support countries in achieving fairer pricing of pharmaceutical products

The Forum was hosted by the South African National Department of Health together with WHO, and attended by representatives from Member States, non-governmental and patient organizations, and the innovator and generic pharmaceutical industry (full list of participants available in Annex A). The Forum consisted of a series of participatory workshops, followed by plenary and parallel panel discussions on key issues of current interest, and concluded by a plenary discussion on key learnings and commitments for further action.